Sound Pharmaceuticals, Inc.

• Candidates must be between 18-75 years of age
• Has a diagnosis of probable or definite Ménière's Disease
• At least two of three active symptoms (fluctuating hearing; tinnitus; aural fullness; vertigo or dizziness) of Ménière's disease.
• Cannot have significant cardiovascular, pulmonary, hepatic, renal, hematologic, gastrointestinal, endocrine, immunologic, neurological or psychiatric disease.
  
  • Length of study: 6 or 12 months
  • Oral medication
• Study drug, exams, diagnostic tests, and blood work are covered and are free of charge to the patient
• Compensation for time and travel

Study conducted by:

Principal Investigator – Mark H. Widick, MD
Sub-Investigator – Diana del Valle, MD
5130 Linton Blvd., Suite E2, Delray Beach, Florida 33484

If you want further information concerning this study, contact

• Delphine Coles at 561-939-0186 or This email address is being protected from spambots. You need JavaScript enabled to view it.